Document is current
Any future updates will be listed below
-
Authors
Sabbagh, Marwan N.
DeCourt, Boris
- License Information
-
More Information
Article History
First Online: 10 January 2023
Competing interests
: B.D. has consulted for Seq Biomarque and TransDermix. M.N.S. has ownership interests (stock or stock options) in Alzheon, Athira Pharma, Cortexyme/Quince Therapeutics, Lighthouse Pharmaceuticals, NeuroReserve, NeuroTau, Seq BioMarque, TransDermix, and uMethod Health; has consulted for Corium, Eisai, Lilly, NeuroTherapia, Novo Nordisk, Prothena, Roche-Genentech, Signant Health, Synaptogenix, and T3D; has received royalties from Humanix; and is on the board of directors of EIP Pharma.
